Users Stopping Weight-Loss Injections Regain Pounds Far More Rapidly Compared to Those on Conventional Diets

A recent study reveals that people who come off new weight-loss injections like Wegovy and Mounjaro can put back on shed pounds much more quickly than those who end traditional diet and exercise programs.

Published data in a prominent medical journal shows that while overweight people often shed about a fifth of their body weight while on the medication, the mass returns at an average rate of 0.8 kg per month upon discontinuation.

"People purchasing these drugs should be cognizant of the danger of quick weight regain when the therapy is stopped," stated researcher Dr. Susan Jebb.

That rate of recovery suggests a return to original weight in about one and a half years.

Comparing Therapies

The analysis, which examined 37 of studies involving over 9,000 of patients, contrasted the results of these new drugs with older methods.

Scientists emphasize that people who lose weight through lifestyle changes alone typically see a more gradual weight regain—perhaps 0.1 kg a month—post-intervention.

Understanding the Quick Regain

Doctors believe the mechanism of the drugs accounts for the accelerated regain.

GLP-1 drugs mimic a natural hormone called GLP-1, which controls hunger.

"Long-term administration of GLP-1 concentrations several times higher than the body's typical production could lead to the system to produce less of its endogenous GLP-1, and may also lessen sensitivity to its actions," said Dr. Adam Collins, a dietetics specialist.

"Discontinuation of this hormone supplement means hunger is uncontrolled, making excessive eating much more probable."

An Ongoing Condition?

Health authorities recommend the jabs for people with weight-linked medical conditions, alongside recommended lifestyle changes.

A number of clinicians argue that, considering the high risk of weight regain, the treatment is often life-long.

This perspective is echoed by pharmaceutical companies, who state that the findings "highlight the persistent nature of obesity," akin to managing conditions like hypertension.

User Accounts

People who have stopped the jabs describe a sudden return of hunger.

"I experienced something activating and you're instantly ravenous," described a patient.

This challenge is worsened if individuals have not established lasting dietary or behavioural changes during therapy.

Significant Interest

Figures indicate that a significant number of people in the UK have used these injections in the past year, with desire being substantial.

• Use is higher among women than males.
• The middle-aged age group shows the greatest level of interest.
• Many obtain the medications through private prescriptions rather than the NHS.

In conclusion, clinicians stress that while GLP-1 drugs are effective agents for shedding pounds, they are not a permanent cure and lasting health benefits relies on ongoing behavioural support.